D-ALBA Front-Line Sequential Treatment of Adult Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) Patients With Dasatinib and the Bispecific Monoclonal Antibody Blinatumomab
Phase of Trial: Phase II
Latest Information Update: 26 Mar 2018
At a glance
- Drugs Blinatumomab (Primary) ; Dasatinib (Primary) ; Prednisone
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 09 Oct 2017 Planned End Date changed from 1 Jun 2020 to 1 Jun 2021.
- 09 Oct 2017 Planned primary completion date changed from 1 Jun 2020 to 1 Jun 2021.
- 09 Oct 2017 Status changed from not yet recruiting to recruiting.